Invention Grant
- Patent Title: Identifying taxane sensitivity in prostate cancer patients
-
Application No.: US14429657Application Date: 2013-09-19
-
Publication No.: US09671405B2Publication Date: 2017-06-06
- Inventor: Paraskevi Giannakakou , Stephen R. Plymate
- Applicant: Cornell University , University of Washington
- Applicant Address: US NY Ithaca US WA Seattle
- Assignee: Cornell University,University of Washington
- Current Assignee: Cornell University,University of Washington
- Current Assignee Address: US NY Ithaca US WA Seattle
- Agency: Schwegman Lundberg & Woessner, P.A.
- International Application: PCT/US2013/060616 WO 20130919
- International Announcement: WO2014/047285 WO 20140327
- Main IPC: A61K31/337
- IPC: A61K31/337 ; C12Q1/68 ; G01N33/574
Abstract:
The invention relates to detection and/or treatment of a subset of prostate cancer patients who may benefit from taxane treatment. The method comprises testing whether an androgen receptor (AR) splice variant is present in a test sample obtained from the patient, wherein the androgen receptor variant can be ARv5,6,7.
Public/Granted literature
- US20150233927A1 IDENTIFYING TAXANE SENSITIVITY IN PROSTATE CANCER PATIENTS Public/Granted day:2015-08-20
Information query
